Clearwater Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clearwater Capital Advisors's LLY Position: Q2 2026 in Review
Clearwater Capital Advisors increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $189K and bringing the position to 1,287 shares worth $1.54M. The position accounts for 0.11% of the portfolio, ranked #62.
Clearwater Capital Advisors first reported a position in LLY in Q1 2018 and has held it in 24 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Clearwater Capital Advisors held 1,287 shares of Eli Lilly worth $1.54M as of Q2 2026.
- Clearwater Capital Advisors bought 185 Eli Lilly shares in Q2 2026, an estimated $189K.
- Eli Lilly made up 0.11% of Clearwater Capital Advisors's portfolio in Q2 2026, its #62 holding.
- Clearwater Capital Advisors first reported a position in Eli Lilly in Q1 2018 and has held it in 24 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Clearwater Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.